{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:42:39Z","timestamp":1764002559396,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Infantile neuroaxonal dystrophy (INAD) is a subtype of PLA2G6-Associated Neurodegeneration (PLAN) with an age of early onset and severe clinical phenotypes of neurodegeneration. Individuals affected with INAD are characterized by rapid progressive psychomotor deterioration, neuroregression, and hypotonia followed by generalized spasticity, optic atrophy, and dementia. In this case, we aimed to identify the underlying causative genetic factors of a Chinese family with two siblings who presented with walking difficulty and inability to speak. We provided a prenatal diagnosis for the family and information for the prevention of this genetic disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective clinical information and magnetic resonance imaging (MRI) findings of the proband were collected. Trio-whole exome sequencing (WES) including the proband and his parents was performed to explore the genetic causes, while Sanger sequencing was subsequently used to validate the variants identified by Trio-WES in the pedigree. Furthermore, prenatal molecular genetic diagnosis was carried out through amniocentesis to investigate the status of pathogenic mutations in the fetus by Sanger sequencing at an appropriate gestational age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The two siblings were both clinically diagnosed with rapid regression in psychomotor development milestones. Brain MRI showed cerebellar atrophy and typical bilaterally symmetrical T2\/FLAIR hyperintense signal changes in periventricular areas, indicating periventricular leukomalacia, and myelin sheath dysplasia. Trio-WES revealed two heterozygous variants in <jats:italic>PlA2G6<\/jats:italic> associated with clinical manifestations in the proband: a novel maternally inherited variant c.217C&amp;gt;T (p.Gln73<jats:sup>*<\/jats:sup>) and a previously reported paternally inherited recurrent pathogenic variant c.1894C&amp;gt;T (p.Arg632Trp). These two heterozygous mutations were also detected in the younger brother who had similar clinical features as the proband. The novel variant c.217C&amp;gt;T was classified as \u201cpathogenic (PVS1 + PM2 + PP3),\u201d while the variant c.1894C&amp;gt;T was \u201cpathogenic\u201d (PS1 + PM1 + PM2 + PM3 + PP3) based on the latest American College of Medical Genetics and Genomics (ACMG) guidelines on sequence variants. Combining the molecular evidence and clinical phenotypes, the diagnosis of INAD was established for the two affected siblings. The two variants that were identified were considered the causative mutations for INAD in this family. Prenatal diagnosis suggested compound heterozygous mutations of c.217C&amp;gt;T and c.1894C&amp;gt;T in the fetus, indicating a high risk of INAD, and the parents chose to terminate the pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We identified a novel pathogenic mutation that broadens the mutation spectrum of <jats:italic>PLA2G6<\/jats:italic> and will provide clues for the molecular diagnosis of INAD. Furthermore, our study has helped to elucidate the causative genetic factors of this Chinese family with INAD effectively and efficiently by using the emerging Trio-WES strategy and providing precise genetic counseling for this family.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.904027","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T14:35:27Z","timestamp":1657118127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of a Novel Nonsense Mutation in PLA2G6 and Prenatal Diagnosis in a Chinese Family With Infantile Neuroaxonal Dystrophy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yongyi","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1086\/508572","article-title":"PLA2G6 mutation underlies infantile neuroaxonal dystrophy","volume":"79","author":"Khateeb","year":"2006","journal-title":"Am J Hum Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-020-01355-2","article-title":"The natural history of infantile neuroaxonal dystrophy","volume":"15","author":"Altuame","year":"2020","journal-title":"Orphanet J Rare Dis."},{"volume-title":"PLA2G6-Associated Neurodegeneration[M]. GeneReviews [Internet]","year":"1993","author":"Gregory","key":"B3"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A(2)","volume":"71","author":"Gregory","year":"2008","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","article-title":"Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)","volume":"70","author":"Kurian","year":"2008","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fneur.2018.01100","article-title":"PLA2G6-associated neurodegeneration (PLAN): review of clinical phenotypes and genotypes","volume":"9","author":"Guo","year":"2018","journal-title":"Front Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1074\/jbc.273.1.207","article-title":"Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity","volume":"273","author":"Larsson","year":"1998","journal-title":"J Biol Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.bbrc.2004.05.225","article-title":"Catalytic residues of group VIB calcium-independent phospholipase A2 (iPLA2gamma)","volume":"320","author":"Tanaka","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1523\/JNEUROSCI.4354-07.2008","article-title":"Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease","volume":"28","author":"Shinzawa","year":"2008","journal-title":"J Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1212\/wnl.43.1_part_1.110","article-title":"The use of magnetic resonance imaging in diagnosing infantile neuroaxonal dystrophy","volume":"43","author":"Tanabe","year":"1993","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejpn.2008.01.005","article-title":"Infantile neuroaxonal dystrophy: what's most important for the diagnosis","volume":"12","author":"Carrilho","year":"2008","journal-title":"Eur J Paediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1468-1331.2012.03856.x","article-title":"Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration","volume":"20","author":"Zhang","year":"2013","journal-title":"Eur J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1468-1331.2008.02397.x","article-title":"Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy","volume":"16","author":"Wu","year":"2009","journal-title":"Eur J Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3892\/etm.2018.6347","article-title":"Infantile neuroaxonal dystrophy caused by PLA2G6 gene mutation in a Chinese patient: a case report","volume":"16","author":"Wang","year":"2018","journal-title":"Exp Ther Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3760\/cma.j.issn.1003-9406.2016.01.016","article-title":"A novel homozygous mutation in PLA2G6 gene causes infantile neuroaxonal dystrophy in a case","volume":"33","author":"Wang","year":"2016","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"B16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.7499\/j.issn.1008-8830.2019.09.002","article-title":"Clinical features of infantile neuroaxonal dystrophy and PLA2G6 gene testing","volume":"21","author":"Lu","year":"2019","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3760\/cma.j.issn.1003-9406.2020.01.006","article-title":"Analysis of PLA2G6 gene variant in a family affected with infantile neuroaxonal dystrophy","volume":"37","author":"Tan","year":"2020","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0221227","DOI":"10.1371\/journal.pone.0221227","article-title":"Multilevel regression modeling for aneuploidy classification and physical separation of maternal cell contamination facilitates the QF-PCR based analysis of common fetal aneuploidies","volume":"14","author":"Noveski","year":"2019","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41467-018-03193-0","article-title":"The structure of iPLA(2)\u03b2 reveals dimeric active sites and suggests mechanisms of regulation and localization","volume":"9","author":"Malley","year":"2018","journal-title":"Nat Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1110\/ps.03554604","article-title":"The ankyrin repeat as molecular architecture for protein recognition","volume":"13","author":"Mosavi","year":"2004","journal-title":"Protein Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8567","DOI":"10.1074\/jbc.272.13.8567","article-title":"A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs","volume":"272","author":"Tang","year":"1997","journal-title":"J Biol Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1074\/jbc.M010439200","article-title":"Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. Implications for structure and function","volume":"276","author":"Jenkins","year":"2001","journal-title":"J Biol Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.10.013","article-title":"PLA2G6-associated neurodegeneration: new insights into brain abnormalities and disease progression","volume":"61","author":"Darling","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e76831","DOI":"10.1371\/journal.pone.0076831","article-title":"New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations","volume":"8","author":"Salih","year":"2013","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2014.03.008","article-title":"PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease","volume":"112","author":"Illingworth","year":"2014","journal-title":"Mol Genet Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1212\/WNL.0b013e3181b2851b","article-title":"Neurodegeneration associated with genetic defects in phospholipase A2","volume":"73","author":"Sadeh","year":"2009","journal-title":"Neurology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-642-47449-1_3","article-title":"Neuropathological conditions related to neuroaxonal dystrophy","volume":"5","author":"Seitelberger","year":"1971","journal-title":"Acta Neuropathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2008.061929","article-title":"Clinical and genetic delineation of neurodegeneration with brain iron accumulation","volume":"46","author":"Gregory","year":"2009","journal-title":"J Med Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jns.2017.08.3260","article-title":"A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy","volume":"381","author":"Iannello","year":"2017","journal-title":"J Neurol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.braindev.2014.04.010","article-title":"Downbeat nystagmus as the presenting symptom of infantile neuroaxonal dystrophy: a case report","volume":"37","author":"Frattini","year":"2015","journal-title":"Brain Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2051-5960-1-12","article-title":"Extensive aggregation of \u03b1-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site","volume":"1","author":"Riku","year":"2013","journal-title":"Acta Neuropathol Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1212\/wnl.52.7.1472","article-title":"Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria","volume":"52","author":"Nardocci","year":"1999","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12098-014-1608-z","article-title":"Molecular diagnosis of infantile neuro axonal dystrophy by next generation sequencing","volume":"82","author":"Goyal","year":"2015","journal-title":"Indian J Pediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"952","DOI":"10.5692\/clinicalneurol.50.952","article-title":"Whole exome sequencing","volume":"50","author":"Nuytemans","year":"2010","journal-title":"Rinsho Shinkeigaku."},{"key":"B36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(11)70196-X","article-title":"Exome sequencing: a transformative technology","volume":"10","author":"Singleton","year":"2011","journal-title":"Lancet Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0140-6736(18)32042-7","article-title":"Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study","volume":"393","author":"Petrovski","year":"2019","journal-title":"Lancet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.904027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T14:35:38Z","timestamp":1657118138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.904027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":37,"alternative-id":["10.3389\/fneur.2022.904027"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.904027","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"904027"}}